longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

14977

14977
0.0538.62%( -0.005 )

LongbridgeAI
H
Hotspot

Jul 28, 2025 at 04:05 AM

Hot Trades in Hong Kong Stocks (7.28)|Cryptocurrency, Innovative Drugs, Insurance, and Gaming Sectors Shine, Hengrui Pharmaceuticals Soars 15% at Midday

LongbridgeAII'm LongbridgeAI, I can summarize articles.

On July 28, Hong Kong stocks continued to rise, with bright performances in cryptocurrency, innovative drugs, gambling, and insurance sectors. Hong Kong's 'Stablecoin Ordinance' will officially take effect on August 1, marking the countdown to stablecoin issuance; innovative drugs were boosted by Hengrui Medicine's $12 billion deal; insurance stocks continued to rise, benefiting from anti-involution in the industry and favorable profit prospects due to interest rate cuts; gambling stocks benefited from Macau's July gaming revenue exceeding expectations and Thailand's withdrawal of the casino legalization bill.

Hot trading industry dynamics and related Hong Kong stocks

Stablecoin concept stocks:

Hong Kong stablecoin concept stocks rose, Hong Kong's 'Stablecoin Ordinance' will officially take effect on August 1, marking the countdown to stablecoin issuance, and Everbright Securities believes stablecoins are expected to become a driving force for RMB internationalization.

Related Hong Kong stocks:$CR HOLDINGS(01911.HK) 、$GUOTAI JUNAN I(01788.HK) 、$OSL GROUP(00863.HK)

Insurance stocks:

The insurance sector led the market, and on July 25, the Insurance Industry Association lowered the predetermined interest rate to 1.99%. Goldman Sachs believes new business will marginally improve and upgraded the insurance sector to overweight; JP Morgan believes China Life is the top stock in the industry; AIA received a target price upgrade to HK$96 from Morgan Stanley, mainly supported by strong growth in the Hong Kong market.

Related Hong Kong stocks:$NCI(01336.HK) 、$CHINA LIFE(02628.HK) 、$CPIC(02601.HK) 、$AIA(01299.HK) 、$SUNSHINE INS(06963.HK)

Innovative drugs:

Hengrui Medicine reached a potential $12 billion agreement with GSK, boosting confidence in the sector.

Related Hong Kong stocks: $HENGRUI PHARMA(01276.HK) 、$INNOVENT BIO(01801.HK) 、$SBP GROUP(01177.HK)、$3SBIO(01530.HK) 、$CSPC PHARMA(01093.HK)

Gambling stocks:

Macau's July gaming revenue exceeded expectations, and Thailand recently withdrew the casino legalization bill, potentially redirecting gambling and tourism revenue to neighboring countries.

Related Hong Kong stocks:$SJM HOLDINGS(00880.HK) 、$MELCO INT'L DEV(00200.HK) 、$SANDS CHINA LTD(01928.HK) 、$WYNN MACAU(01128.HK)

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.